REGN vs TPB · P/E 14, rev $14.34B vs P/E 27, $1.32B cap
Regeneron Pharmaceuticals Inc (REGN) versus Turning Point Brands Inc (TPB) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Turning Point Brands Inc (TPB) is a tobacco company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
TPB does not have a complete income-statement cache yet.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TPB currently screens at market cap $1.32B and trailing P/E 27.5.
Not investment advice. Open the REGN and TPB stock pages for the full models.
Not investment advice.